Maxime M Vroegindewey1, Rohit M Oemrawsingh1,2, Isabella Kardys1, Folkert W Asselbergs3,4,5,6, Pim van der Harst7, Anton J Oude Ophuis8,9, G Etienne Cramer10, Arthur Maas11, S Hong Kie The12, Alexander J Wardeh13, Henk Mouthaan14, Eric Boersma1, K Martijn Akkerhuis1. 1. a Department of Cardiology , Erasmus University Medical Centre , Rotterdam , The Netherlands. 2. b Department of Cardiology , Amphia Hospital , Breda , The Netherlands. 3. c Department of Cardiology Division Heart & Lungs , University Medical Centre, Utrecht University of Utrecht , Utrecht , The Netherlands. 4. d Durrer Centre for Cardiovascular Research Netherlands Heart Institute , Utrecht , The Netherlands. 5. e Faculty of Population Health Sciences , Institute of Cardiovascular Science, University College London , London , UK. 6. f Farr Institute of Health Informatics Research and Institute of Health Informatics, University College London , London , UK. 7. g University Medical Centre Groningen , Groningen , The Netherlands. 8. h Canisius-Wilhelmina Hospital , Nijmegen , The Netherlands. 9. i Working Group on Cardiovascular Research the Netherlands (WCN) , Utrecht , The Netherlands. 10. j Radboud University Medical Center , Nijmegen , The Netherlands. 11. k Gelre Hospital , Zutphen , The Netherlands. 12. l Treant Zorggroep, Bethesda , Hoogeveen , The Netherlands. 13. m Haaglanden Medisch Centrum , Den Haag , The Netherlands. 14. n Olink Proteomics , Uppsala , Sweden.
Abstract
PURPOSE: We assessed the temporal pattern of 29 immune and inflammatory proteins in post-acute coronary syndrome (ACS) patients, prior to the development of recurrent ACS. METHODS: High-frequency blood sampling was performed in 844 patients admitted for ACS during one-year follow-up. We conducted a case-control study on the 45 patients who experienced reACS (cases) and two matched event-free patients (controls) per case. Olink Proteomics' immunoassay was used to obtain serum levels of the 29 proteins, expressed in an arbitrary unit on the log2-scale (Normalized Protein eXpression, NPX). Linear mixed-effects models were applied to examine the temporal pattern of the proteins, and to illustrate differences between cases and controls. RESULTS: Mean age was 66 ± 12 years and 80% were men. Cases and controls had similar baseline clinical characteristics. During the first 30 days, and after multiple testing correction, cases had significantly higher serum levels of CXCL1 (difference of 1.00 NPX, p = 0.002), CD84 (difference of 0.64 NPX, p = 0.002) and TNFRSF10A (difference of 0.41 NPX, p < 0.001) than controls. After 30 days, serum levels of all 29 proteins were similar in cases and controls. In particular, no increase was observed prior to reACS. CONCLUSIONS: Among 29 immune and inflammatory proteins, CXCL1, CD84 and TNFRSF10A were associated with early reACS after initial ACS-admission.
PURPOSE: We assessed the temporal pattern of 29 immune and inflammatory proteins in post-acute coronary syndrome (ACS) patients, prior to the development of recurrent ACS. METHODS: High-frequency blood sampling was performed in 844 patients admitted for ACS during one-year follow-up. We conducted a case-control study on the 45 patients who experienced reACS (cases) and two matched event-free patients (controls) per case. Olink Proteomics' immunoassay was used to obtain serum levels of the 29 proteins, expressed in an arbitrary unit on the log2-scale (Normalized Protein eXpression, NPX). Linear mixed-effects models were applied to examine the temporal pattern of the proteins, and to illustrate differences between cases and controls. RESULTS: Mean age was 66 ± 12 years and 80% were men. Cases and controls had similar baseline clinical characteristics. During the first 30 days, and after multiple testing correction, cases had significantly higher serum levels of CXCL1 (difference of 1.00 NPX, p = 0.002), CD84 (difference of 0.64 NPX, p = 0.002) and TNFRSF10A (difference of 0.41 NPX, p < 0.001) than controls. After 30 days, serum levels of all 29 proteins were similar in cases and controls. In particular, no increase was observed prior to reACS. CONCLUSIONS: Among 29 immune and inflammatory proteins, CXCL1, CD84 and TNFRSF10A were associated with early reACS after initial ACS-admission.
Authors: Mihaela Ioana Dregoesc; Adrian Bogdan Ţigu; Siroon Bekkering; Charlotte D C C van der Heijden; Sorana Daniela Bolboacǎ; Leo A B Joosten; Frank L J Visseren; Mihai G Netea; Niels P Riksen; Adrian Corneliu Iancu Journal: Front Cardiovasc Med Date: 2022-02-08